CLINICAL PHARMACOLOGY POSTMARKETING STUDIES: A US FDA EVALUATION OF KNOWLEDGE GAPS AND TRANSLATION INTO LABELING.

被引:0
|
作者
Ridge, S. [1 ]
Guinn, D. [1 ]
Fletcher, E. Pfuma [1 ]
Zineh, I. [1 ]
Madabushi, R. [1 ]
Ramamoorthy, A. [1 ]
机构
[1] US FDA, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PT-017
引用
下载
收藏
页码:S66 / S67
页数:2
相关论文
共 44 条
  • [1] US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing Information
    Ridge, Sarah
    Guinn, Daphne
    Fletcher, Elimika Pfuma
    Zineh, Issam
    Madabushi, Rajanikanth
    Ramamoorthy, Anuradha
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (06): : 695 - 703
  • [2] Assessment of clinical pharmacology information (CPI) in drug labeling.
    Spyker, DA
    Harvey, ED
    Harvey, BE
    Harvey, AM
    Rumack, BH
    Peck, CC
    Atkinson, AJ
    Woosley, RL
    Abernethy, DR
    Cantilena, LR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII4 - PII4
  • [3] An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System
    Kathryn Marwitz
    S. Christopher Jones
    Cindy M. Kortepeter
    Gerald J. Dal Pan
    Monica A. Muñoz
    Drug Safety, 2020, 43 : 457 - 465
  • [4] An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System
    Marwitz, Kathryn
    Jones, S. Christopher
    Kortepeter, Cindy M.
    Dal Pan, Gerald J.
    Munoz, Monica A.
    DRUG SAFETY, 2020, 43 (05) : 457 - 465
  • [5] Pharmacogenomic data submissions to the FDA:: clinical pharmacology case studies
    Ruaño, G
    Collins, JM
    Dorner, AJ
    Wang, SJ
    Guerciolini, R
    Huang, SM
    PHARMACOGENOMICS, 2004, 5 (05) : 513 - 517
  • [6] Clinical Lactation Studies of Neuropsychiatric Medications: Clinical Pharmacology and Labeling Considerations
    Nallani, Srikanth C.
    Baisden, Kristie
    Dinatale, Miriam
    Basham, Lisa
    Kwatra, Deep
    Yao, Lynne
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 : S159 - S169
  • [7] Pharmacogenomics and drug development: the impact of US FDA postapproval tracking on clinical pharmacology
    Farrell, Erin
    Usuka, Jonathan
    PERSONALIZED MEDICINE, 2008, 5 (02) : 133 - 139
  • [8] Pediatric Formulations: Knowledge Gaps Limiting the Expedited Preclinical to Clinical Translation in Children
    Lavan, Monika
    Byrn, Stephen R.
    Knipp, Gregory
    AAPS PHARMSCITECH, 2019, 20 (02)
  • [9] Pediatric Formulations: Knowledge Gaps Limiting the Expedited Preclinical to Clinical Translation in Children
    Monika Lavan
    Stephen R. Byrn
    Gregory Knipp
    AAPS PharmSciTech, 20
  • [10] Preclinical to Clinical Translation of Hemodynamic Effects in Cardiovascular Safety Pharmacology Studies
    Bhatt, Siddhartha
    Northcott, Carrie
    Wisialowski, Todd
    Li, Dingzhou
    Steidl-Nichols, Jill
    TOXICOLOGICAL SCIENCES, 2019, 169 (01) : 272 - 279